ArticleFrontiers in oncology2026

Efficacy and safety of radiotherapy combined with chemoimmunotherapy versus chemoimmunotherapy alone as first-line treatment for metachronous oligorecurrent esophageal squamous cell carcinoma.

Xiaoyan Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.